Organisation paid for research Program year 2025 Source: CMS Open Payments

Consano Clinical Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$1,061,234

1,536 payments

Through program year 2025, Consano Clinical Research, LLC is reported as receiving $1,061,234 in research payments, across 1,536 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $294,229 7
2024 Research $93,560 730
2023 Research $186,184 40
2022 Research $131,627 85
2021 Research $140,725 475
2020 Research $67,148 66
2019 Research $147,762 133

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novo Nordisk AS $395,483 1,496 payments
  2. AstraZeneca Pharmaceuticals LP $239,368 5 payments
  3. Ascendis Pharma, Inc. $201,238 12 payments
  4. AbbVie, Inc. $79,311 12 payments
  5. Genentech, Inc. $64,555 7 payments
  6. Amgen Inc. $42,647 2 payments
  7. Senseonics, Incorporated $38,631 2 payments
Studies the money was for Research payments · program years 2019–2025
  1. Nn9924-4635 $215,688 147 payments
  2. A Phase II Randomised Double blind Placebo controlled Study to Evaluate the Efficacy Safety and Tolerability of AZD6234 in Participants Living with Obesity or Overweight with Comorbidity $195,819 1 payment
  3. foresiGHt $150,928 6 payments
  4. Nn9535-4352 $80,620 417 payments
  5. M16-100 $79,311 12 payments
  6. A Phase Ib Randomized Blinded Placebo Controlled Multiple Ascending Dose Study With Bfkb8488a $64,555 7 payments
  7. foresiGHt extension $50,310 6 payments
  8. Nn9535-4801 $41,337 598 payments
  9. Senseonics CTP0034 PAS $38,631 2 payments
  10. A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity $36,153 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record